For: | Kinoshita C, Nagano T, Seki N, Tomita Y, Sugita T, Aida Y, Itagaki M, Satoh K, Sutoh S, Abe H, Tsubota A, Aizawa Y. Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles. World J Gastroenterol 2016; 22(29): 6716-6725 [PMID: 27547014 DOI: 10.3748/wjg.v22.i29.6716] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i29/6716.htm |
Number | Citing Articles |
1 |
Shizuya Yamashita, Mitsuyo Okazaki, Takeshi Okada, Daisaku Masuda, Koutaro Yokote, Hidenori Arai, Eiichi Araki, Shun Ishibashi. Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate. Journal of Atherosclerosis and Thrombosis 2021; 28(9): 974 doi: 10.5551/jat.60764
|
2 |
Gilmar de Souza Lacerda, Thalia Medeiros, Natalia Fonseca do Rosário, Regina Helena Saramago Peralta, Mauro Jorge Cabral-Castro, Eliane Bordalo Cathalá Esberard, Thaís Guaraná de Andrade, Analúcia Rampazzo Xavier, Andrea Alice Silva. Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment. Clinical Biochemistry 2018; 60: 17 doi: 10.1016/j.clinbiochem.2018.07.007
|
3 |
Alankrita Rani, Julia T. Stadler, Gunther Marsche. HDL-based therapeutics: A promising frontier in combating viral and bacterial infections. Pharmacology & Therapeutics 2024; 260: 108684 doi: 10.1016/j.pharmthera.2024.108684
|